Opportunities include earlier CKD screening, combination cardiorenal regimens, disease-modifying therapies, and precision treatments for APOL1-driven disease. Cell therapies and treatments for ...
BACKGROUND: Direct reprogramming of cardiac fibroblasts (CFs) into induced cardiomyocytes (iCMs) holds promise as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results